Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of GE HealthCare Technologies Inc (NASDAQ: GEHC) closed at $85.3 in the last session, up 0.63% from day before closing price of $84.77. In other words, the price has increased by $0.63 from its previous closing price. On the day, 3.72 million shares were traded. GEHC stock price reached its highest trading level at $85.41 during the session, while it also had its lowest trading level at $83.56.
Ratios:
We take a closer look at GEHC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.75. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on October 13, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $86.
On October 07, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $83.
UBS Upgraded its Sell to Neutral on May 05, 2025, while the target price for the stock was maintained at $73.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Kenneth Stacherski bought 4,585 shares for $77.00 per share.
Kenneth Stacherski bought 4,585 shares of GEHC for $361,993 on Oct 27 ’25. On Sep 22 ’25, another insider, Kenneth Stacherski, who serves as the Former Officer of the company, bought 19,524 shares for $74.46 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 38944743424 and an Enterprise Value of 45821992960. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.64, and their Forward P/E ratio for the next fiscal year is 17.24. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.92 while its Price-to-Book (P/B) ratio in mrq is 3.89. Its current Enterprise Value per Revenue stands at 2.263 whereas that against EBITDA is 12.637.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.23, which has changed by -0.002705872 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be 14.27%.
Shares Statistics:
According to the various share statistics, GEHC traded on average about 3.41M shares per day over the past 3-months and 2622840 shares per day over the past 10 days. A total of 455.51M shares are outstanding, with a floating share count of 454.26M. Insiders hold about 0.28% of the company’s shares, while institutions hold 85.79% stake in the company. Shares short for GEHC as of 1767139200 were 11202509 with a Short Ratio of 3.28, compared to 1764288000 on 11138672. Therefore, it implies a Short% of Shares Outstanding of 11202509 and a Short% of Float of 3.25.
Earnings Estimates
The market rating of GE HealthCare Technologies Inc (GEHC) is currently shaped by the ongoing analysis conducted by 15.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.99, with high estimates of $1.17 and low estimates of $0.9.
Analysts are recommending an EPS of between $4.6 and $4.51 for the fiscal current year, implying an average EPS of $4.55. EPS for the following year is $4.93, with 20.0 analysts recommending between $5.06 and $4.55.
Revenue Estimates
According to 15 analysts,. The current quarter’s revenue is expected to be $5.6B. It ranges from a high estimate of $5.7B to a low estimate of $5.47B. As of. The current estimate, GE HealthCare Technologies Inc’s year-ago sales were $5.32BFor the next quarter, 15 analysts are estimating revenue of $5B. There is a high estimate of $5.12B for the next quarter, whereas the lowest estimate is $4.93B.
A total of 20 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.63B, while the lowest revenue estimate was $20.18B, resulting in an average revenue estimate of $20.5B. In the same quarter a year ago, actual revenue was $19.67BBased on 18 analysts’ estimates, the company’s revenue will be $21.39B in the next fiscal year. The high estimate is $21.71B and the low estimate is $21.11B.
